Catalyst Wire Dossier Catalyst Wire Dossier

Amlenetug (Lu AF82422)

amlenetug · H. Lundbeck A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Amlenetug (Lu AF82422), covering 2026-06-04 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) [Phase 3]

See pricing